North America Pharmaceutical Processing Equipment Market

Description

List of Tables

North America pharmaceutical processing equipment market is expected to reach USD 14,302.23 million by 2031, from USD 7,601.90 million in 2023 growing at the CAGR of 8.52% in the forecast period of 2024 to 2031.

Market Segmentation

North America Pharmaceutical Processing Equipment Market, By Equipment (Mixers, Blenders, Granulators, Pumps, Heat Exchanges, and Others), Dosage Type (Solid Dosage Processing Equipment, Liquid Dosage Processing Equipment, and Semi-Solid Dosage Equipment), Processing Type (Upstream Processing and Downstream Processing), Application (Mixing & Blending, Granulation, Drying, Tablet Compression, Capsule Filling, and Others), End User (Pharmaceutical & Biopharmaceutical Companies, Contract research Organization, R&D Laboratories, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2031

Overview of North America Pharmaceutical Processing Equipment Market Dynamics

Drivers
Increasing demand for pharmaceutical products
Growing demand for high containment equipment
Rising innovations in material science
Increasing focus on quality by design (QbD)
Restraints
Supply chain disruptions
Complexity of equipment validation
Maintenance and operational costs
Opportunities
Integration of advanced manufacturing technologies
Digitalization and data analytics in processing and production
Paradigm towards single use technologies
Challenges
Shortage of skilled labor in pharmaceutical processing
Intense competition from global manufacturers in processing

Market Players

The key market players for global pharmaceutical processing equipment market are listed below:

Thermo Fisher Scientific Inc.
ALFA LAVAL
GEA Group Aktiengsellschaft
SPX FLOW, Inc.
I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A
ACG
Syntegon Technology GmbH
Paul Mueller Company
FREUND Corp.
Gansons
Alexanderwerk AG
B&P Littleford
Chamunda Pharma Machinery
Prism Pharma Machinery
SaintyCo
Nicomac Srl
United Pharmatek USA
ADINATH INTERNATIONAL
NU PHARMA ENGINEERS & CONSULTANT
Senieer

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.10 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS
4.2 PORTES FIVE FORCES

5 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET: REGULATIONS

5.1 FOOD AND DRUG ADMINISTRATION (FDA) - U.S.:
5.2 EMA REGULATIONS (EUROPEAN UNION):
5.3 ICH GUIDELINES ((INTERNATIONAL CONFERENCE ON HARMONIZATION):
5.4 ISO STANDARDS:

6 MARKET OVERVIEW

6.1 DRIVERS
- 6.1.1 INCREASING DEMAND FOR PHARMACEUTICAL PRODUCTS
- 6.1.2 GROWING DEMAND FOR HIGH CONTAINMENT EQUIPMENT
- 6.1.3 RISING INNOVATIONS IN MATERIAL SCIENCE
- 6.1.4 INCREASING FOCUS ON QUALITY BY DESIGN (QBD)
6.2 RESTRAINTS
- 6.2.1 SUPPLY CHAIN DISRUPTIONS
- 6.2.2 COMPLEXITY OF EQUIPMENT VALIDATION
- 6.2.3 MAINTENANCE AND OPERATIONAL COSTS
6.3 OPPORTUNITIES
- 6.3.1 INTEGRATION OF ADVANCED MANUFACTURING TECHNOLOGIES
- 6.3.2 DIGITALIZATION AND DATA ANALYTICS IN PROCESSING AND PRODUCTION
- 6.3.3 PARADIGM TOWARDS SINGLE USE TECHNOLOGIES
6.4 CHALLENGES
- 6.4.1 SHORTAGE OF SKILLED LABOR IN PHARMACEUTICAL PROCESSING
- 6.4.2 INTENSE COMPETITION FROM NORTH AMERICA MANUFACTURERS IN PROCESSING
- 6.4.3 LACK OF QUALITY DESIGNS IN PROCESSING EQUIPMENT

7 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY EQUIPMENT

7.1 OVERVIEW
7.2 MIXERS
7.3 BLENDERS
7.4 GRANULATORS
7.5 PUMPS
7.6 HEAT EXCHANGERS
7.7 OTHERS

8 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY PROCESSING TYPE

8.1 OVERVIEW
8.2 UPSTREAM PROCESSING
8.3 DOWNSTREAM PROCESSING

9 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY DOSAGE TYPE

9.1 OVERVIEW
9.2 SOLID DOSAGE PROCESSING EQUIPMENT
9.3 LIQUID DOSAGE PROCESSING EQUIPMENT
9.4 SEMI-SOLID DOSAGE PROCESSING EQUIPMENT

10 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY APPLICATION

10.1 OVERVIEW
10.2 MIXING & BLENDING
10.3 GRANULATION
10.4 DRYING
10.5 TABLET COMPRESSION
10.6 CAPSULE FILLING
10.7 OTHERS

11 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY END USER

11.1 OVERVIEW
11.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
11.3 CONTRACT RESEARCH ORGANIZATION
11.4 R&D LABORATORIES
11.5 OTHERS

12 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL

12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL SALES
12.4 OTHER

13 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION

13.1 NORTH AMERICA
- 13.1.1 U.S
- 13.1.2 CANADA
- 13.1.3 MEXICO

14 SWOT ANALYSIS

15 COMPANY PROFILES

15.1 THERMO FISHER SCIENTIFIC INC.
- 15.1.1 COMPANY SNAPSHOT
- 15.1.2 REVENUE ANALYSIS
- 15.1.3 COMPANY SHARE ANALYSIS
- 15.1.4 PRODUCT PORTFOLIO
- 15.1.5 RECENT DEVELOPMENT
15.2 ALFA LAVAL
- 15.2.1 COMPANY SNAPSHOT
- 15.2.2 REVENUE ANALYSIS
- 15.2.3 COMPANY SHARE ANALYSIS
- 15.2.4 PRODUCT PORTFOLIO
- 15.2.5 RECENT DEVELOPMENTS
15.3 GEA GROUP AKTIENGESELLSCHAFT
- 15.3.1 COMPANY SNAPSHOT
- 15.3.2 REVENUE ANALYSIS
- 15.3.3 COMPANY SHARE ANALYSIS
- 15.3.4 PRODUCT PORTFOLIO
- 15.3.5 RECENT DEVELOPMENT
15.4 SPX FLOW, INC.
- 15.4.1 COMPANY SNAPSHOT
- 15.4.2 COMPANY SHARE ANALYSIS
- 15.4.3 PRODUCT PORTFOLIO
- 15.4.4 RECENT DEVELOPMENTS
15.5 I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A
- 15.5.1 COMPANY SNAPSHOT
- 15.5.2 COMPANY SHARE ANALYSIS
- 15.5.3 PRODUCT PORTFOLIO
- 15.5.4 RECENT DEVELOPMENT
15.6 ACG
- 15.6.1 COMPANY SNAPSHOT
- 15.6.2 COMPANY SHARE ANALYSIS
- 15.6.3 PRODUCT PORTFOLIO
- 15.6.4 RECENT DEVELOPMENT
15.7 SYNTEGON TECHNOLOGY GMBH, 2024
- 15.7.1 COMPANY SNAPSHOT
- 15.7.2 PRODUCT PORTFOLIO
- 15.7.3 RECENT DEVELOPMENT
15.8 PAUL MUELLER COMPANY
- 15.8.1 COMPANY SNAPSHOT
- 15.8.2 REVENUE ANALYSIS
- 15.8.3 PRODUCT PORTFOLIO
- 15.8.4 RECENT DEVELOPMENT.
15.9 FREUND CORP.
- 15.9.1 COMPANY SNAPSHOT
- 15.9.2 REVENUE ANALYSIS
- 15.9.3 PRODUCT PORTFOLIO
- 15.9.4 RECENT DEVELOPMENT
15.10 GANSONS
- 15.10.1 COMPANY SNAPSHOT
- 15.10.2 PRODUCT PORTFOLIO
- 15.10.3 RECENT DEVELOPMENTS
15.11 ALEXANDERWERK AG 2024
- 15.11.1 COMPANY SNAPSHOT
- 15.11.2 REVENUE ANALYSIS
- 15.11.3 PRODUCT PORTFOLIO
- 15.11.4 RECENT DEVELOPMENT
15.12 B&P LITTLEFORD
- 15.12.1 COMPANY SNAPSHOT
- 15.12.2 PRODUCT PORTFOLIO
- 15.12.3 RECENT DEVELOPMENTS
15.13 CHAMUNDA PHARMA MACHINERY
- 15.13.1 COMPANY SNAPSHOT
- 15.13.2 PRODUCT PORTFOLIO
- 15.13.3 RECENT DEVELOPMENT
15.14 PRISM PHARMA MACHINERY
- 15.14.1 COMPANY SNAPSHOT
- 15.14.2 PRODUCT PORTFOLIO
- 15.14.3 RECENT DEVELOPMENT
15.15 SAINTYCO
- 15.15.1 COMPANY SNAPSHOT
- 15.15.2 PRODUCT PORTFOLIO
- 15.15.3 RECENT DEVELOPMENT
15.16 NICOMAC SRL
- 15.16.1 COMPANY SNAPSHOT
- 15.16.2 PRODUCT PORTFOLIO
- 15.16.3 RECENT DEVELOPMENTS
15.17 UNITED PHARMATEK USA
- 15.17.1 COMPANY SNAPSHOT
- 15.17.2 PRODUCT PORTFOLIO
- 15.17.3 RECENT DEVELOPMENT
15.18 ADINATH INTERNATIONAL
- 15.18.1 COMPANY SNAPSHOT
- 15.18.2 PRODUCT PORTFOLIO
- 15.18.3 RECENT DEVELOPMENT
15.19 NU PHARMA ENGINEERS & CONSULTANT
- 15.19.1 COMPANY SNAPSHOT
- 15.19.2 PRODUCT PORTFOLIO
- 15.19.3 RECENT DEVELOPMENT
15.20 SENIEER
- 15.20.1 COMPANY SNAPSHOT
- 15.20.2 PRODUCT PORTFOLIO
- 15.20.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

LIST OF TABLES

TABLE 1 THE PHARMACEUTICAL INDUSTRY: A KEY ASSET TO THE EUROPEAN ECONOMY
TABLE 2 AVERAGE HVAC SYSTEM INSTALLATION COST
TABLE 3 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY EQUIPMENT, 2022-2031 (USD MILLION)
TABLE 4 NORTH AMERICA MIXERS IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 5 NORTH AMERICA BLENDERS IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 6 NORTH AMERICA GRANULATORS IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 7 NORTH AMERICA PUMPS IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 8 NORTH AMERICA HEAT EXCHANGERS IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 9 NORTH AMERICA OTHERS IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 10 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY PROCESSING TYPE, 2022-2031 (USD MILLION)
TABLE 11 NORTH AMERICA UPSTREAM PROCESSING IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 12 NORTH AMERICA DOWNSTREAM PROCESSING IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 13 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY DOSAGE TYPE, 2022-2031 (USD MILLION)
TABLE 14 NORTH AMERICA SOLID DOSAGE PROCESSING EQUIPMENT IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 15 NORTH AMERICA LIQUID DOSAGE PROCESSING EQUIPMENT IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 16 NORTH AMERICA SEMI-SOLID DOSAGE PROCESSING EQUIPMENT IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 17 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 18 NORTH AMERICA MIXING & BLENDING IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 19 NORTH AMERICA GRANULATION IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 20 NORTH AMERICA DRYING IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 21 NORTH AMERICA TABLET COMPRESSION IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 22 NORTH AMERICA CAPSULE FILLING IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 23 NORTH AMERICA OTHERS IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 24 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 25 NORTH AMERICA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 26 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 27 NORTH AMERICA R&D LABORATORIES IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 28 NORTH AMERICA OTHERS IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 29 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 30 NORTH AMERICA DIRECT TENDER IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 31 NORTH AMERICA RETAIL SALES IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 32 NORTH AMERICA OTHERS IN PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 33 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 34 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY EQUIPMENT, 2022-2031 (USD MILLION)
TABLE 35 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY DOSAGE TYPE, 2022-2031 (USD MILLION)
TABLE 36 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY PROCESSING TYPE, 2022-2031 (USD MILLION)
TABLE 37 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 38 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 39 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 40 U.S. PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY EQUIPMENT, 2022-2031 (USD MILLION)
TABLE 41 U.S. PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY DOSAGE TYPE, 2022-2031 (USD MILLION)
TABLE 42 U.S. PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY PROCESSING TYPE, 2022-2031 (USD MILLION)
TABLE 43 U.S. PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 44 U.S. PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 45 U.S. PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 46 CANADA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY EQUIPMENT, 2022-2031 (USD MILLION)
TABLE 47 CANADA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY DOSAGE TYPE, 2022-2031 (USD MILLION)
TABLE 48 CANADA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY PROCESSING TYPE, 2022-2031 (USD MILLION)
TABLE 49 CANADA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 50 CANADA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 51 CANADA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 52 MEXICO PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY EQUIPMENT, 2022-2031 (USD MILLION)
TABLE 53 MEXICO PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY DOSAGE TYPE, 2022-2031 (USD MILLION)
TABLE 54 MEXICO PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY PROCESSING TYPE, 2022-2031 (USD MILLION)
TABLE 55 MEXICO PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 56 MEXICO PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 57 MEXICO PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

LIST OF FIGURES

FIGURE 1 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET: SEGMENTATION
FIGURE 11 REGIONAL REVENUE, KEY PLAYERS, PATENT ANALYSIS AND R&D EXPENDITURE
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET, BY EQUIPMENT
FIGURE 14 INCREASING DEMAND FOR PHARMACEUTICAL PRODUCTS IS DRIVING THE GROWTH OF THE NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET FROM 2024 TO 2031
FIGURE 15 THE MIXERS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET IN 2024 AND 2031
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA PHARMACEUTICALS PROCESSING EQUIPMENT MARKET
FIGURE 17 NUMBER OF OLDER AMERICANS, 1960-2040 (IN MILLIONS)
FIGURE 18 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET: BY EQUIPMENT, 2023
FIGURE 19 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET: BY EQUIPMENT, 2024-2031 (USD MILLION)
FIGURE 20 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET: BY EQUIPMENT, CAGR (2024-2031)
FIGURE 21 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET: BY EQUIPMENT, LIFELINE CURVE
FIGURE 22 NORTH AMERICA PHARMACEUTICAL PROCESSING TYPE MARKET: BY PROCESSING TYPE, 2023
FIGURE 23 NORTH AMERICA PHARMACEUTICAL PROCESSING TYPE MARKET: BY PROCESSING TYPE, 2024-2031 (USD MILLION)
FIGURE 24 NORTH AMERICA PHARMACEUTICAL PROCESSING TYPE MARKET: BY PROCESSING TYPE, CAGR (2024-2031)
FIGURE 25 NORTH AMERICA PHARMACEUTICAL PROCESSING TYPE MARKET: BY PROCESSING TYPE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA PHARMACEUTICAL PROCESSING DOSAGE TYPE MARKET: BY DOSAGE TYPE, 2023
FIGURE 27 NORTH AMERICA PHARMACEUTICAL PROCESSING DOSAGE TYPE MARKET: BY DOSAGE TYPE, 2024-2031 (USD MILLION)
FIGURE 28 NORTH AMERICA PHARMACEUTICAL PROCESSING DOSAGE TYPE MARKET: BY DOSAGE TYPE, CAGR (2024-2031)
FIGURE 29 NORTH AMERICA PHARMACEUTICAL PROCESSING DOSAGE TYPE MARKET: BY DOSAGE TYPE, LIFELINE CURVE
FIGURE 30 NORTH AMERICA PHARMACEUTICAL PROCESSING APPLICATION MARKET: BY APPLICATION, 2023
FIGURE 31 NORTH AMERICA PHARMACEUTICAL PROCESSING APPLICATION MARKET: BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 32 NORTH AMERICA PHARMACEUTICAL PROCESSING APPLICATION MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 33 NORTH AMERICA PHARMACEUTICAL PROCESSING APPLICATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 34 NORTH AMERICA PHARMACEUTICAL PROCESSING END USER MARKET: BY END USER, 2023
FIGURE 35 NORTH AMERICA PHARMACEUTICAL PROCESSING END USER MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 36 NORTH AMERICA PHARMACEUTICAL PROCESSING END USER MARKET: BY END USER, CAGR (2024-2031)
FIGURE 37 NORTH AMERICA PHARMACEUTICAL PROCESSING END USER MARKET: BY END USER, LIFELINE CURVE
FIGURE 38 NORTH AMERICA PHARMACEUTICAL PROCESSING DISTRIBUTION CHANNEL MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 39 NORTH AMERICA PHARMACEUTICAL PROCESSING DISTRIBUTION CHANNEL MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)
FIGURE 40 NORTH AMERICA PHARMACEUTICAL PROCESSING DISTRIBUTION CHANNEL MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 41 NORTH AMERICA PHARMACEUTICAL PROCESSING DISTRIBUTION CHANNEL MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 NORTH AMERICA PHARMACEUTICAL PROCESSING EQUIPMENT MARKET: SNAPSHOT (2023)